Search Results

Showing results 41 - 50 of 3233.
Sort By: Date ▼

A new peanut allergy drug could cost $4,200 a year. Is it just overpriced peanut flour?

September 18, 2019


An FDA advisory panel this month recommended approval of an experimental treatment for peanut allergies but, writing in The Atlantic, James Hamblin questions whether the product is worth its likely $4,200 price tag—and flags research suggesting it might backfire for some patients.

A monthly subscription to an air ambulance? Regulators say it might be too good to be true.

September 18, 2019


Some air ambulance companies are selling membership subscriptions that promise patients will pay no out-of-pocket costs if they use the transportation services, but state regulators—and some larger air ambulance companies—are skeptical of the memberships' no-cost guarantee.

FDA finds cancer-causing chemical in another US drug

September 17, 2019


FDA on Friday announced that it has found low levels of a chemical that could cause cancer in some batches of medications commonly used to treat heartburn, but it has not issued recalls of the drugs at this time.

In the states: Florida provider pays $85K to settle alleged HIPAA violation, New York to require warnings in vape stores, and more

September 13, 2019


American Health Line rounds up the latest health care news in the states.

FDA is planning to ban unauthorized flavored e-cigarettes

September 12, 2019


The Trump administration on Wednesday announced that FDA intends to finalize a compliance policy that will clear the market of unauthorized, non-tobacco-flavored e-cigarettes, including mint and menthol flavors, in response to growing numbers of children using e-cigarettes.

FTC cracks down on CBD products with unsupported claims they treat diseases

September 12, 2019


The Federal Trade Commission on Tuesday announced that it has warned three companies for advertising that their cannabidiol products can treat medical conditions without evidence to support those claims.

Men are missing out on 'lifesaving' breast cancer therapies—and FDA wants that to change

September 12, 2019


FDA recently released draft guidance that calls on researchers to include more male patients in clinical trials for breast cancer therapies in response to concerns that men are missing out on lifesaving treatments.

The uninsured rate is up for the first time in nearly a decade, Census data shows

September 11, 2019


New data from the U.S. Census Bureau show the country's uninsured rate increased from 7.9% in 2017 to 8.5% in 2018, marking the first year-to-year increase reflected in Census data since 2008 to 2009, when the United States was at the highest point of the Great Recession.

FDA warns Juul for marketing products as safer than traditional cigarettes

September 11, 2019


FDA on Monday announced that it has warned e-cigarette maker Juul Labs for illegally marketing its nicotine pods as a less harmful alternative to traditional cigarettes, and for doing so in a presentation to youth at a U.S. school.

Google to ban ads for unproven cell, gene, and stem cell therapies

September 10, 2019


Google on Friday announced a new policy banning advertisements for "unproven or experimental medical techniques," including most cellular, gene, and stem cell therapies.

Results Page: [Previous] 1 2 3 4 5  ... [Next]